FERMENTA BIOTECH Financial Statement Analysis
|
||
|
The Revenues of FERMENTA BIOTECH have decreased by -4.08% YoY .
The Earnings Per Share (EPS) of FERMENTA BIOTECH has increased by Positive YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
FERMENTA BIOTECH Last 5 Annual Financial Results
[BOM: 506414]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹336 Cr | ₹350 Cr | ₹399 Cr | ₹377 Cr | ₹293 Cr |
| Expenses | ₹308 Cr | ₹332 Cr | ₹336 Cr | ₹295 Cr | ₹229 Cr |
| Operating Profit (Excl OI) | ₹28 Cr | ₹18 Cr | ₹62 Cr | ₹83 Cr | ₹64 Cr |
| Other Income | ₹12 Cr | ₹8.60 Cr | ₹8.25 Cr | ₹8.37 Cr | ₹14 Cr |
| Interest | ₹17 Cr | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹20 Cr |
| Depreciation | ₹25 Cr | ₹28 Cr | ₹26 Cr | ₹20 Cr | ₹15 Cr |
| Profit Before Tax | ₹-9.87 Cr | ₹-51 Cr | ₹27 Cr | ₹52 Cr | ₹43 Cr |
| Profit After Tax | ₹-24 Cr | ₹-53 Cr | ₹15 Cr | ₹43 Cr | ₹60 Cr |
| Consolidated Net Profit | ₹-23 Cr | ₹-51 Cr | ₹15 Cr | ₹46 Cr | ₹60 Cr |
| Earnings Per Share (Rs) | ₹26.35 | ₹-7.99 | ₹-17.70 | ₹5.35 | ₹15.77 |
| PAT Margin (%) | 16.27 | -7.15 | -15.18 | 3.78 | 11.27 |
| ROE(%) | 23.93 | -8.30 | -16.11 | 4.27 | 13.05 |
| ROCE(%) | 21.97 | 1.58 | -5.25 | 7.50 | 12.62 |
| Total Debt/Equity(x) | 0.30 | 0.48 | 0.72 | 0.66 | 0.66 |
Key Financials |
||
| Market Cap | : | ₹ 1,039.3 Cr |
| Revenue (TTM) | : | ₹ 562.8 Cr |
| Net Profit(TTM) | : | ₹ 110.8 Cr |
| EPS (TTM) | : | ₹ 37.7 |
| P/E (TTM) | : | 9.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FERMENTA BIOTECH | 0.7% | 26.9% | -10.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.9% | -1.8% | -2.5% |
| DIVIS LABORATORIES | 2.1% | 0.2% | 9.1% |
| CIPLA | 0.7% | -0.8% | 3.4% |
| TORRENT PHARMACEUTICALS | 0.5% | 2.2% | 11.2% |
| DR REDDYS LABORATORIES | -0.1% | 2.5% | 2.5% |
| MANKIND PHARMA | 1.5% | -2.8% | -19.5% |
| ZYDUS LIFESCIENCES | -0.2% | -0.8% | -5.7% |
| LUPIN | 1.7% | 4.7% | 3.5% |
FERMENTA BIOTECH Revenues
[BOM: 506414]
| Y-o-Y | -4.08 % |
| 5 Yr CAGR | 3.46 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹336 Cr | -4.08 | |
| Mar2024 | ₹350 Cr | -12.19 | |
| Mar2023 | ₹399 Cr | 5.63 | |
| Mar2022 | ₹377 Cr | 28.79 | |
| Mar2021 | ₹293 Cr | - | |
FERMENTA BIOTECH Operating Profit
[BOM: 506414]
| Y-o-Y | 53.28 % |
| 5 Yr CAGR | -18.85 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | 53.28 | |
| Mar2024 | ₹18 Cr | -70.76 | |
| Mar2023 | ₹62 Cr | -24.64 | |
| Mar2022 | ₹83 Cr | 28.41 | |
| Mar2021 | ₹64 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 59.81 % |
| 5 Yr CAGR | -21.56 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 8.31% | 59.81 | |
| Mar2024 | 5.2% | -66.71 | |
| Mar2023 | 15.62% | -28.64 | |
| Mar2022 | 21.89% | -0.27 | |
| Mar2021 | 21.95% | - | |
FERMENTA BIOTECH Profit After Tax
[BOM: 506414]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-23 Cr | Negative | |
| Mar2024 | ₹-51 Cr | Negative | |
| Mar2023 | ₹15 Cr | -66.06 | |
| Mar2022 | ₹46 Cr | -23.55 | |
| Mar2021 | ₹60 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | 9.61 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 16.27 % | Positive | |
| Mar2024 | -7.15 % | Negative | |
| Mar2023 | -15.18 % | Negative | |
| Mar2022 | 3.78 % | -66.46 | |
| Mar2021 | 11.27 % | - | |
FERMENTA BIOTECH Earnings Per Share (EPS)
[BOM: 506414]
| Y-o-Y | Positive |
| 5 Yr CAGR | 13.69 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 | Positive | |
| Mar2024 | ₹-7.99 | Negative | |
| Mar2023 | ₹-18 | Negative | |
| Mar2022 | ₹5.35 | -66.07 | |
| Mar2021 | ₹16 | - | |
FERMENTA BIOTECH Return on Capital Employed (ROCE)
[BOM: 506414]
| Y-o-Y | 1,290.51 % |
| 5 Yr CAGR | 14.87 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 21.97% | 1,290.51 | |
| Mar2024 | 1.58% | Positive | |
| Mar2023 | -5.25% | Negative | |
| Mar2022 | 7.5% | -40.57 | |
| Mar2021 | 12.62% | - | |
FERMENTA BIOTECH Share Price vs Sensex
| Current Share Price | : | ₹353.5 |
| Current MarketCap | : | ₹ 1,039.3 Cr |
| Updated EOD on | : | Dec 19,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | 0.7% |
26.9% |
-10.3% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
FERMENTA BIOTECH related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | -0.2% | -3.8% | -11.2% |
| BSE HEALTHCARE | -0.3% | -1.6% | -0.5% |
No NSE index found
You may also like the below Video Courses
FAQ about FERMENTA BIOTECH Financials
How the annual revenues of FERMENTA BIOTECH have changed ?
The Revenues of FERMENTA BIOTECH have decreased by -4.08% YoY .
How the Earnings per Share (EPS) of FERMENTA BIOTECH have changed?
The Earnings Per Share (EPS) of FERMENTA BIOTECH has increased by Positive YoY .
Check out Intrinsic Value of Peers of FERMENTA BIOTECH
Compare Stock Analytics of Peers of FERMENTA BIOTECH
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
